Skip to main content
Premium Trial:

Request an Annual Quote

Sequencing When It Rains, It Nanopores


When Celera said it would sequence the human genome in three years, skeptics said it couldn’t be done. But for some, even that isn’t fast enough. “Today sequencing is too slow, too expensive, and inaccessible,” says Stephen Laderman, who heads the molecular diagnostic department at Agilent Technologies.

With Agilent’s funding, Harvard biologist Daniel Branton and physicist Jene Golovchenko, along with David Deamer of the University of California at Santa Cruz, are in the early stages of developing a technology they say would sequence an entire human genome in less than two hours.

Inspired by their cell membrane work, Branton and Beamer use a lipid bilayer, an ion gradient, and a membrane protein to take advantage of DNA’s negative charge. A DNA strand is piped through the membrane by changes in electrical charge. The idea is, as it shuttles through a 1.5 nanometer pore in the protein, each base identifies itself with a distinct electrical current.

The nanopore sequencer is likely up to a decade away from commercial viability. For one thing, the researchers are looking to replace the unstable protein pore with a solid-state material. “We’d like to use higher temperatures in order to keep the molecules single-stranded. But that’s not possible with a protein, which will be cooked like an egg,” says Branton. Another kink is the speed at which DNA flies through the pore: at a million bases a second, it’s too fast for today’s detectors to handle.

— Aaron J. Sender


The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.